Organization
Huahui Health
11 clinical trials
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Phase 1 Study to Assess the Safety, Tolerability, Preliminary Efficacy of Inhaled HH-120 Aerosol in Participants With Mild to Moderate COVID-19Status: Completed, Estimated PCD: 2022-10-10
Clinical trial
A Randomized, Placebo-controlled, Single-Ascending Dose Phase Ia Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-12-29
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple-dose HH-003 Injection in Treatment Naïve Participants With HBeAg-positive Chronic HBV InfectionStatus: Completed, Estimated PCD: 2022-03-15
Clinical trial
A Multicenter, Randomized, Controlled, Open-label Phase IIb Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus InfectionStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
An Open-label Phase IIa Study to Evaluate the Antiviral Effect and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and D Co-infectionStatus: Terminated, Estimated PCD: 2022-07-25
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Assess the Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19Status: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Multicenter, Randomized, Controlled Phase IIa Study to Evaluate the Antiviral Activity and Safety of HH-003 in Nucleos(t)Ide Analogues-treated Chronic Hepatitis B Subjects With Low-Level ViremiaStatus: Active (not recruiting), Estimated PCD: 2023-04-24
Clinical trial
A Phase III, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of HH-120 Nasal Spray for Post-exposure Prophylaxis of SARS-CoV-2Status: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic and Immunogenicity of HH-120 Nasal Spray in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-01-09
Clinical trial
A Double-Blinded, Randomized, and Placebo-Controlled Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics Profile of Single and Multiple Ascending Doses of Inhaled HH-120 Aerosol in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-05-26
Clinical trial
A Multicenter, Randomized, Controlled Phase IIa Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase InhibitorsStatus: Completed, Estimated PCD: 2022-12-05